David Cruikshank is a Vice President with ARCH Venture Partners.
Mr. Cruikshank joined the company as an Associate in August 2007. Mr. Cruikshank focuses on electronics/instrumentation, advanced materials, medical diagnostics & devices, nanotechnology, semiconductors, and information technologies. He has been instrumental in identifying and leading the due diligence on ARCH investments in Ultivue, Voxel8, Cytrellis Biosystems, Twist Bioscience, 908 Devices, PixelEXX Systems, Boreal Genomics, and Ciespace, and has served as board observer and provided operating assistance to these companies as well. Mr. Cruikshank was formerly with Toshiba America Electronic Components as an engineer and manager in Business Development and was responsible for North American audio, video, and automotive semiconductor product lines with annual sales of $50 million. Prior to that, he was with Conexant Systems (originally Rockwell Semiconductor) as an Industrial Engineer.
Mr. Cruikshank holds an MBA with Honors from the University of Chicago, an M.S. in Industrial Engineering and Operations Research from University of California, Berkeley, and a B.S. in Mechanical Engineering from the University of California, Los Angeles, where he graduated Summa Cum Laude and was elected to Phi Beta Kappa.